What’s new in adipocytic neoplasia?
Adipocytic tumors are frequently encountered in routine practice, and while the vast majority represent commonly encountered tumor types (e.g., benign lipoma), the heterogeneity and rarity of other adipocytic neoplasms can pose diagnostic challenges. Atypical and malignant adipocytic tumors account for approximately 20% of all sarcomas. The 2013 World Health Organization (WHO) classification of soft tissue and bone tumors recognizes four major liposarcoma subtypes, characterized by distinct clinical behavior, distinctive morphologies, as well as unique genetic findings: atypical lipomatous tumor/well-differentiated liposarcoma, dedifferentiated liposarcoma, myxoid liposarcoma, and pleomorphic liposarcoma. Since the publication of the 2013 WHO classification of soft tissue and bone tumors, the most notable change in the category of adipocytic tumors has been made in the clinicopathologic and molecular characterization of the heterogeneous but distinct group of “atypical low-grade adipocytic neoplasms with spindle cell features,” for which the term atypical spindle cell/pleomorphic lipomatous tumor has been proposed. Another substantive change in the group of adipocytic tumors is the introduction of pleomorphic myxoid liposarcoma (myxoid pleomorphic liposarcoma) as an apparently novel subtype of aggressive liposarcoma, especially occurring in children and young adults with a predilection for the mediastinum. This review will further focus upon the diagnostic criteria of these novel emerging entities in the group of adipocytic tumors.
KeywordsAtypical spindle cell/pleomorphic lipomatous tumor Spindle cell/pleomorphic lipoma Pleomorphic myxoid liposarcoma Pleomorphic liposarcoma RB1 MDM2
Compliance with ethical standards
The author has complied with all ethical standards as outlined on the Virchows Archives website.
Conflict of interest
The author declares that he has no conflicts of interest.
- 1.Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F (2013) World Health Organization Classification of Tumours. Pathology and Genetics. In: Tumours of Soft Tissue and Bone. IARC, LyonGoogle Scholar
- 5.Fletcher CDM, Unni KK, Mertens F (2002) World Health Organization Classification of Tumours. Pathology and Genetics. In: Tumours of Soft Tissue and Bone. IARC, LyonGoogle Scholar
- 6.Marino-Enriquez A, Fletcher CDM, Dal Cin P, Hornick JL (2010) Dedifferentiated liposarcoma with “homologous” lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria. Am J Surg Pathol 34:1122–1131CrossRefGoogle Scholar
- 13.Nascimento AF, Fletcher CDM (2005) Spindle cell liposarcoma/atypical lipomatous tumor. A clinicopathologic study of 120 cases. Mod Pathol 8:70AGoogle Scholar
- 15.Creytens D, Mentzel T, Ferdinande L, Lecoutere E, van Gorp J, Atanesyan L, de Groot K, Savola S, Van Roy N, Van Dorpe J, Flucke U (2017) “Atypical” pleomorphic lipomatous tumor: a clinicopathologic, immunohistochemical and molecular study of 21 cases, emphasizing its relationship to atypical spindle cell lipomatous tumor and suggesting a morphologic spectrum (‘atypical spindle cell/pleomorphic lipomatous tumor’). Am J Surg Pathol 41(11):1443–1455CrossRefGoogle Scholar
- 17.Mentzel T, Palmedo G, Kuhnen C (2010) Well-differentiated spindle cell liposarcoma (‘atypical spindle cell lipomatous tumor’) does not belong to the spectrum of atypical lipomatous tumor but has a close relationship to spindle cell lipoma: clinicopathologic, immunohistochemical analysis of six cases. Mod Pathol 23(5):729–736CrossRefGoogle Scholar
- 19.Creytens D, van Gorp J, Savola S, Ferdinande L, Mentzel T, Libbrecht L (2014) Atypical spindle cell lipoma: a clinicopathologic, immunohistochemical, and molecular study emphasizing its relationship to classical spindle cell lipoma. Virchows Arch 465(1):97–108Google Scholar
- 24.Creytens D, Mentzel T, Ferdinande L, van Gorp J, Van Dorpe J, Flucke U (2019) “Fat-rich” (spindle cell-poor) variants of atypical spindle cell lipomatous tumors show similar morphologic, immunohistochemical and molecular features as “dysplastic lipomas”: are they related lesions? Comment on Michal et al (2018). Am J Surg Pathol 43(2):288–289CrossRefGoogle Scholar
- 25.Creytens D, Mentzel T, Ferdinande L, van Gorp J, Van Dorpe J, Flucke U (2019) “Fat-rich” (spindle cell-poor) variant of atypical spindle cell/pleomorphic lipomatous tumor: striking mimic of “classical” atypical lipomatous tumor/well-differentiated liposarcoma. Int J Surg Pathol Epub ahead of print:106689691984656Google Scholar
- 26.Michal M, Agaimy A, Contreras AL, Svajdler M, Kazakov DV, Steiner P, Grossmann P, Martinek P, Hadravsky L, Michalova K, Svajdler P, Szep Z, Michal M, Fetsch JF (2018) Dysplastic lipoma: a distinctive atypical lipomatous neoplasm with anisocytosis, focal nuclear atypia, p53 overexpression, and a lack of MDM2 gene amplification by FISH: a report of 66 cases demonstrating occasional multifocality and a rare association with retinoblastoma. Am J Surg Pathol 4211:1530–1540CrossRefGoogle Scholar
- 27.Agaimy A (2017) Anisometric cell lipoma: insight from a case series and review of the literature on adipocytic neoplasms in survivors of retinoblastoma suggest a role for RB1 loss and possible relationship to fat-predominant (“fat-only”) spindle cell lipoma. Ann Diagn Pathol 29:52–56CrossRefGoogle Scholar
- 28.Evans HL (2015) Subcutaneous minimally atypical lipomatous tumors with variable fat cell size—a study of 13 cases. Mod Pathol 28(suppl2):17AGoogle Scholar
- 32.Schaefer IM, Hornick JL (2018) Diagnostic immunohistochemistry for soft tissue and bone tumors: an update. Adv Anat Pathol 25:400–412Google Scholar